You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Moxifloxacin

Showing 26 - 50 of 649
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Endophthalmitis, Open Globe Injury, Moxifloxacin Trial in Campinas (Moxifloxacin Ophthalmic 0.5% Ophthalmic Solution,

Recruiting
  • Endophthalmitis
  • +3 more
  • Moxifloxacin Ophthalmic 0.5% Ophthalmic Solution
  • Ciprofloxacin 400 MG/200 ML Intravenous Solution [CIPRO IV]
  • Campinas, Brazil
    University of Campinas
Dec 6, 2021

Healthy Subjects Trial in Rennes (Combined oral contraceptives (COC), Moxifloxacin 400mg, Cenerimod 0.5 mg)

Completed
  • Healthy Subjects
  • Combined oral contraceptives (COC)
  • +5 more
  • Rennes, France
    Site 1
Nov 15, 2022

Drug-induced QT Prolongation, Pharmacokinetics, Pharmacodynamics Trial in West Bend (Clarithromycin, Pimozide, Placebo (Part 1))

Not yet recruiting
  • Drug-induced QT Prolongation
  • +2 more
  • West Bend, Wisconsin
    Spaulding Clinical Research
Feb 7, 2023

Breast Cancer Trial in Guangzhou (standard adjuvant chemo plus moxifloxacin, standard adjuvant chemo plus )

Recruiting
  • Breast Cancer
  • standard adjuvant chemotherapy plus moxifloxacin
  • standard adjuvant chemotherapy plus placebo
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 14, 2021

Healthy Subjects Trial in Mannheim (Aprocitentan 25 mg, Aprocitentan 100 mg, Matching )

Completed
  • Healthy Subjects
  • Aprocitentan 25 mg
  • +3 more
  • Mannheim, Baden-Württemberg, Germany
    CRS Clinical Research Services Mannheim GmbH
Nov 22, 2022

Pulmonary Tuberculosis, Other Specified Pulmonary Tuberculosis Trial in Worldwide (Sutezolid, Rifampicin, Isoniazid)

Recruiting
  • Pulmonary Tuberculosis
  • Other Specified Pulmonary Tuberculosis
  • Lambaréné, Gabon
  • +7 more
Apr 17, 2023

Rhegmatogenous Retinal Detachment Trial in Boston (Pars plana vitrectomy, Triamcinolone Acetonide 40mg/mL, Moxifloxacin 0.5% or

Recruiting
  • Rhegmatogenous Retinal Detachment
  • Pars plana vitrectomy
  • +4 more
  • Boston, Massachusetts
    Massachusetts Eye and Ear
Jul 26, 2022

Infections and Infestations, Pulmonary Tuberculosis Trial in South Africa, Tanzania (Delpazolid, Bedaquiline, Delamanid,

Active, not recruiting
  • Infections and Infestations
  • Pulmonary Tuberculosis
  • Tembisa, Gauteng, South Africa
  • +4 more
Sep 13, 2022

Endophthalmitis, Trauma, Corneal Trial in São Paulo (Intraocular Instillation Solution, Moxifloxacin Ophthalmic)

Recruiting
  • Endophthalmitis
  • Trauma, Corneal
  • Intraocular Instillation Solution
  • Moxifloxacin Ophthalmic
  • São Paulo, SP, Brazil
    Dept of Ophthalmology - UNIFESP/Hospital São Paulo
Nov 3, 2021

Acanthamoeba Keratitis, Fungal Keratitis Trial in Madurai (Moxifloxacin Ophthalmic, Chlorhexidine Gluconate, Natamycin)

Recruiting
  • Acanthamoeba Keratitis
  • Fungal Keratitis
  • Moxifloxacin Ophthalmic
  • +4 more
  • Madurai, Tamil Nadu, India
    Aravind Eye Care System
Jan 8, 2023

HIV Trial in Austin (GSK3640254, Placebo, Moxifloxacin)

Completed
  • HIV Infections
  • Austin, Texas
    GSK Investigational Site
Nov 16, 2021

Healthy Participants Trial in Tempe (Aficamten, Aficamten-matching Placebo, Moxifloxacin)

Recruiting
  • Healthy Participants
  • Tempe, Arizona
    Celerion, Inc 2420
Jun 27, 2023

Healthy Trial in New Haven (sisunatovir, , moxifloxacin)

Recruiting
  • Healthy
  • New Haven, Connecticut
    New Haven Clinical Research Unit
May 18, 2023

Tuberculosis, Pulmonary Trial (Sitafloxacin, SMZ/TMP, Rifampin)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • (no location specified)
Jul 7, 2022

Cardiac Repolarization Trial in Melbourne (Placebo, Moxifloxacin (positive control), Milademetan)

Not yet recruiting
  • Cardiac Repolarization
  • Placebo
  • +2 more
  • Melbourne, Victoria, Australia
    Nucleus Network Melbourne
Mar 6, 2023

Healthy Volunteer Study Trial in Québec (Bemnifosbuvir (BEM), Placebo, Moxifloxacin)

Completed
  • Healthy Volunteer Study
  • Bemnifosbuvir (BEM)
  • +2 more
  • Québec, Montreal, Quebec, Canada
    Atea Study Site
Jun 14, 2023

Postpartum Hemorrhage Trial in Tempe (Carbetocin, Placebo, Placebo and Moxifloxacin)

Recruiting
  • Postpartum Hemorrhage
  • Tempe, Arizona
    Ferring Investigational Site
Jun 20, 2023

Tuberculous Meningitis Trial in Chennai (High dose rifampicin (25mg/kg), Moxifloxacin 400mg, Aspirin 150 mg)

Not yet recruiting
  • Tuberculous Meningitis
  • High dose rifampicin (25mg/kg)
  • +8 more
  • Chennai, Tamil Nadu, India
    ICMR- National Institute for Research in Tuberculosis
Jun 15, 2023

Schizophrenia Trial (MK-8189, Moxifloxacin, Placebo)

Not yet recruiting
  • Schizophrenia
  • (no location specified)
May 30, 2023

Contraception Trial (Moxifloxacin, NOMAC-E2 (Org 10486-0 + Org 2317), Moxifloxacin )

Completed
  • Contraception
  • Moxifloxacin
  • +3 more
  • (no location specified)
Feb 7, 2022

Smoking Cessation Trial in Porto (Cytisinicline, Placebo, Moxifloxacin)

Completed
  • Smoking Cessation
  • Porto, Portugal
    BlueClinical Phase I
Jan 3, 2023

Community-acquired Pneumonia, Bacterial Pneumonia Trial in Worldwide (Omadacycline, Moxifloxacin)

Recruiting
  • Community-acquired Pneumonia
  • Bacterial Pneumonia
  • Pernik, Bulgaria
  • +29 more
Mar 8, 2022

Healthy Volunteers Trial in Tempe (Epetraborole and matching , Epetraborole, Placebo)

Active, not recruiting
  • Healthy Volunteers
  • Epetraborole and matching placebo
  • +3 more
  • Tempe, Arizona
    423001
Aug 16, 2023

Antibiotic Resistance, Ocular Surface Microbiome, Gut Resistome Trial in San Francisco (Moxifloxacin (Topical))

Recruiting
  • Antibiotic Resistance
  • +2 more
  • Moxifloxacin (Topical)
  • San Francisco, California
    University of California, San Francisco
Aug 2, 2022

Healthy Subjects Trial in Toshima-ku (TS-142, Moxifloxacin, Placebo)

Completed
  • Healthy Subjects
  • Toshima-ku, Japan
    Taisho Pharmaceutical Co., Ltd selected site
Oct 5, 2022